Pfizer scraps insulin deal with India's Biocon

MUMBAI (Reuters) - Pfizer Inc, the world's largest drugmaker, has scrapped a deal to sell insulin products made by Biocon Ltd, leaving India's biggest biotech company without a partner to sell a key profit-driver in global markets.

whos in jail catawba county texas department of criminal justice offender search sacramento jail